Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Juvenile myoclonic epilepsy phenotype in a family with Unverricht-Lundborg disease.

Berrechid AG, Bendjebara M, Bouteiller D, Nasri A, Peuvion JN, Marie Y, Baulac S, Mrabet S, Ribierre T, Cazeneuve C, Imenkacem, Leguern E, Gouider R.

Epileptic Disord. 2019 Aug 1;21(4):359-365. doi: 10.1684/epd.2019.1078.

PMID:
31368437
2.

Late diagnosis of hypophosphatasia in a case with Unverricht-Lundborg disease.

Zouwail S, Longworth N, Grey J, Nesbitt M, Sisodiya S, Hamandi K.

Ann Clin Biochem. 2019 Jul;56(4):515-518. doi: 10.1177/0004563219854110. Epub 2019 May 29. No abstract available.

PMID:
31088113
3.

Unverricht-Lundborg disease: Clinical course and seizure management based on the experience of polish centers.

Lasek-Bal A, Lukasik M, Żak A, Sulek A, Bosak M.

Seizure. 2019 Jul;69:87-91. doi: 10.1016/j.seizure.2019.04.008. Epub 2019 Apr 10.

PMID:
30999254
4.

First Molecular Diagnosis of a Patient with Unverricht-Lundborg Disease in Korea.

Kim KH, Song JS, Park CW, Ki CS, Heo K.

Yonsei Med J. 2018 Aug;59(6):798-800. doi: 10.3349/ymj.2018.59.6.798.

5.

Abnormal motor cortical adaptation to external stimulus in Unverricht-Lundborg disease (progressive myoclonus type 1, EPM1).

Julkunen P, Löfberg O, Kallioniemi E, Hyppönen J, Kälviäinen R, Mervaala E.

J Neurophysiol. 2018 Aug 1;120(2):617-623. doi: 10.1152/jn.00063.2018. Epub 2018 May 9.

6.

Variable course of Unverricht-Lundborg disease: Early prognostic factors.

Canafoglia L, Ferlazzo E, Michelucci R, Striano P, Magaudda A, Gambardella A, Pasini E, Belcastro V, Riguzzi P, Fanella M, Granata T, Beccaria F, Trentini C, Bianchi A, Aguglia U, Panzica F, Franceschetti S.

Neurology. 2017 Oct 17;89(16):1691-1697. doi: 10.1212/WNL.0000000000004518. Epub 2017 Sep 20.

PMID:
28931642
7.

A clinical and neurophysiological motor signature of Unverricht-Lundborg disease.

Hainque E, Blancher A, Mesnage V, Rivaud-Pechoux S, Bertrand A, Dupont S, Navarro V, Roze E, Gourfinkel-An I, Apartis E.

Rev Neurol (Paris). 2018 Jan - Feb;174(1-2):56-65. doi: 10.1016/j.neurol.2017.06.005. Epub 2017 Jul 5.

PMID:
28688606
8.

Perampanel in 12 patients with Unverricht-Lundborg disease.

Crespel A, Gelisse P, Tang NP, Genton P.

Epilepsia. 2017 Apr;58(4):543-547. doi: 10.1111/epi.13662. Epub 2017 Feb 6.

9.

A novel c132-134del mutation in Unverricht-Lundborg disease and the review of literature of heterozygous compound patients.

Assenza G, Benvenga A, Gennaro E, Tombini M, Campana C, Assenza F, Di Pino G, Di Lazzaro V.

Epilepsia. 2017 Feb;58(2):e31-e35. doi: 10.1111/epi.13626. Epub 2016 Nov 26. Review.

10.

The network sustaining action myoclonus: a MEG-EMG study in patients with EPM1.

Franceschetti S, Canafoglia L, Rotondi F, Visani E, Granvillano A, Panzica F.

BMC Neurol. 2016 Nov 7;16(1):214.

11.

Cerebellar Involvement in Patients with Mild to Moderate Myoclonus Due to EPM1: Structural and Functional MRI Findings in Comparison with Healthy Controls and Ataxic Patients.

Nigri A, Visani E, Bertolino N, Nanetti L, Mariotti C, Panzeri M, Bruzzone MG, Franceschetti S, Canafoglia L.

Brain Topogr. 2017 May;30(3):380-389. doi: 10.1007/s10548-016-0534-y. Epub 2016 Oct 26.

PMID:
27785699
12.

Unverricht-Lundborg disease.

Crespel A, Ferlazzo E, Franceschetti S, Genton P, Gouider R, Kälviäinen R, Korja M, Lehtinen MK, Mervaala E, Simonato M, Vaarmann A.

Epileptic Disord. 2016 Sep 1;18(S2):28-37. Review.

PMID:
27582036
13.

Long-term evolution of EEG in Unverricht-Lundborg disease.

Gargouri-Berrechid A, Nasri A, Kacem I, Sidhom Y, Abdelkefi I, Hizem Y, Ben Djebrara M, Gouider R.

Neurophysiol Clin. 2016 Apr;46(2):119-24. doi: 10.1016/j.neucli.2016.03.003. Epub 2016 May 4.

PMID:
27157382
14.

Brivaracetam in Unverricht-Lundborg disease (EPM1): Results from two randomized, double-blind, placebo-controlled studies.

Kälviäinen R, Genton P, Andermann E, Andermann F, Magaudda A, Frucht SJ, Schlit AF, Gerard D, de la Loge C, von Rosenstiel P.

Epilepsia. 2016 Feb;57(2):210-21. doi: 10.1111/epi.13275. Epub 2015 Dec 15.

15.

Refining the phenotype of Unverricht-Lundborg disease (EPM1): a population-wide Finnish study.

Hyppönen J, Äikiä M, Joensuu T, Julkunen P, Danner N, Koskenkorva P, Vanninen R, Lehesjoki AE, Mervaala E, Kälviäinen R.

Neurology. 2015 Apr 14;84(15):1529-36. doi: 10.1212/WNL.0000000000001466. Epub 2015 Mar 13.

PMID:
25770194
16.

Reduced cortical activation in inferior frontal junction in Unverricht-Lundborg disease (EPM1) - A motor fMRI study.

Könönen M, Danner N, Koskenkorva P, Kälviäinen R, Hyppönen J, Mervaala E, Karjalainen P, Vanninen R, Niskanen E.

Epilepsy Res. 2015 Mar;111:78-84. doi: 10.1016/j.eplepsyres.2015.01.006. Epub 2015 Jan 24.

PMID:
25769376
17.

Long-term follow-up of cortical hyperexcitability in Japanese Unverricht-Lundborg disease.

Kobayashi K, Hitomi T, Matsumoto R, Kondo T, Kawamata J, Matsuhashi M, Hashimoto S, Ikeda H, Koide Y, Inoue Y, Takahashi R, Ikeda A.

Seizure. 2014 Oct;23(9):746-50. doi: 10.1016/j.seizure.2014.06.002. Epub 2014 Jun 25.

18.

Seizure control in Unverricht-Lundborg disease: a single-centre study.

Roivainen R, Karvonen MK, Puumala T.

Epileptic Disord. 2014 Jun;16(2):191-5. doi: 10.1684/epd.2014.0654.

19.

EEG-EMG information flow in movement-activated myoclonus in patients with Unverricht-Lundborg disease.

Panzica F, Canafoglia L, Franceschetti S.

Clin Neurophysiol. 2014 Sep;125(9):1803-8. doi: 10.1016/j.clinph.2014.01.005. Epub 2014 Jan 20.

PMID:
24508192
20.

Progressive myoclonic epilepsies: definitive and still undetermined causes.

Franceschetti S, Michelucci R, Canafoglia L, Striano P, Gambardella A, Magaudda A, Tinuper P, La Neve A, Ferlazzo E, Gobbi G, Giallonardo AT, Capovilla G, Visani E, Panzica F, Avanzini G, Tassinari CA, Bianchi A, Zara F; Collaborative LICE study group on PMEs.

Neurology. 2014 Feb 4;82(5):405-11. doi: 10.1212/WNL.0000000000000077. Epub 2014 Jan 2.

Supplemental Content

Loading ...
Support Center